{
  "ticker": "ACL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02960345",
  "id": "02960345",
  "pages": 1,
  "price_sensitive": false,
  "date": "20250620",
  "time": "0921",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250620/pdf/06ky0xx6q5tf10.pdf",
  "summary": "**Board Appointment Announcement:**  \n- **New Chair Appointment:** Mr Stephen Roche appointed as independent non-executive director, transitioning to Chair on **26 August 2025**.  \n- **Current Interim Chair:** Mark Haberlin remains Interim Chair until transition date.  \n- **Experience:** Roche brings 15+ years of public company directorship experience (notably in healthcare and retail sectors).  \n\n**No material trading or capital markets impact identified.**  \n\n*(Omitted: Director background details, non-material operational descriptions, and legal/contact boilerplate.)*",
  "usage": {
    "prompt_tokens": 847,
    "completion_tokens": 113,
    "total_tokens": 960,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-19T23:34:16.757848"
}